Top 3 search results for "Torisel" in Resources. To see all results and access other features, sign up for free.

... be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus (Afinitor) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib (Sutent) Temsirolimus (Torisel ...

... intestines longer than usual.In clinical trials, constipation occurred in: 25 percent of people taking cabozantinib (Cabometyx) 29 percent of people taking lenvatinib (Lenvima) in combination with pembrolizumab (Keytruda) 23 percent of people taking sunitinib (Sutent) 20 percent of people taking axitinib (Inlyta) 20 percent of people taking temsirolimus (Torisel ...

... Two mTOR inhibitors used in metastatic kidney cancer are everolimus (Afinitor) and temsirolimus (Torisel). Everolimus is a pill, and temsirolimus is given as an IV infusion.Doctors can prescribe mTOR inhibitors alone or together with a TKI. For example, the combination of everolimus and lenvatinib is given as a second-line treatment. ...